pharmaceuticals, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, B-cell disorders, and minimal residual diseases, in the form of intravenous, sub-cutaneous, intraperitoneal, intra-muscular and aerosol therapies

'aerosol':53 'allergi':17 'antibodi':5,7 'autoimmun':18 'b':33 'b-cell':32 'cell':34 'coronari':29 'cutan':47 'deriv':8 'diseas':16,21,26,31,39 'disord':35 'form':42 'graft':23 'heart':30 'host':25 'infecti':20 'inflamm':19 'intra':50 'intra-muscular':49 'intraperiton':48 'intraven':44 'minim':37 'muscular':51 'name':2 'osteoporosi':22 'particular':4 'pharmaceut':1 'polypeptid':3 'reject':28 'residu':38 'sub':46 'sub-cutan':45 'therapi':54 'transplant':27 'treatment':13 'tumor':15 'use':10 'versus':24

ITAB

Owners

Goods & Services